Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. ARGX

Market Cap: $61.22B

AS

argenx SE

ARGX
NASDAQ (NASDAQ Global Select)USD
Purchase ARGX
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin89.94%
EBITDA Margin30.62%
EBIT Margin30.31%
Pre-tax Margin33.43%
Net Profit Margin32.87%
Earnings Yield2.77%
Valuation Multiples
Price / Book7.32
Price / Sales11.88
Price / Earnings35.90
PEG0.10
Forward PEG1.02
EV / Sales11.20
EV / EBITDA36.56
EV / Operating Cash Flow51.72
EV / Free Cash Flow51.88
Price / Free Cash Flow55.05
Price / Operating Cash Flow54.87
Cash Flow & Capital
Free Cash Flow / Share$18
Operating Cash Flow / Share$18.05
Free Cash Flow Yield1.82%
Capex / Revenue0.07%
Capex / Operating Cash Flow0.32%
Capex / Depreciation0.12
Stock Compensation / Revenue0.00%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio5.12
Quick Ratio4.89
Cash Ratio2.28
Debt / Assets0.00
Debt / Capital0.01
Debt / Equity0.01
Long-Term Debt / Capital0.00
Debt / Market Cap0.00%
Net Debt / EBITDA-2.23
Solvency Ratio1.07
Financial Leverage1.19
Efficiency & Working Capital
Asset Turnover0.52
Fixed Asset Turnover99.74
Inventory Turnover1.41
Receivables Turnover2.67
Payables Turnover0.73
Days Sales Outstanding136.6
Days Inventory Outstanding259.6
Days Payables Outstanding502.41
Operating Cycle396.2
Cash Conversion Cycle-106.21
Working Capital Turnover0.86
Returns & Quality
Return on Equity21.66%
Return on Assets16.99%
Return on Invested Capital17.36%
ROCE17.67%
Return on Tangible Assets17.45%
Operating Return on Assets15.97%
Income Quality0.66
Tax Burden0.98
Interest Burden1.10
Balance Sheet & Intrinsic Metrics
Enterprise Value$58.07B
Invested Capital$6.81B
Working Capital$6.49B
Tangible Asset Value$8.15B
Net Current Asset Value$6.45B
Graham Number$288.93
Graham Net-Net$83.79
Book Value / Share$135.35
Tangible Book Value / Share$131.08
Cash / Share$83.36
Financial Health Scores
Piotroski Score5
Altman Z-Score21.95
Revenue$7.54B
EBIT$2.22B
Market Cap$52.78B
Working Capital$6.49B
Retained Earnings$558M
Total Assets$10.03B
Total Liabilities$1.62B